Thyroid V30 predicts radiation-induced hypothyroidism in patients treated with sequential chemo-radiotherapy for Hodgkin's lymphoma

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 5, 2012, Pages 1802-1808

  Cella, Laura ^a,b   Conson, Manuel ^b   Caterino, Michele ^b   De Rosa, Nicola ^b   Liuzzi, Raffaele ^a,b   Picardi, Marco ^b   Grimaldi, Francesco ^b   Solla, Raffaele ^a,b   Farella, Antonio ^b   Salvatore, Marco ^b   Pacelli, Roberto ^a,b  

^a CNR   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Dosimetric constraints; Hodgkin's lymphoma; Hypothyroidism; Radiotherapy; Thyroid gland

Indexed keywords

AFTER-TREATMENT; BLOOD LEVELS; COX REGRESSION; DOSE-VOLUME; DOSIMETRIC CONSTRAINTS; DOSIMETRIC PARAMETER; HODGKIN'S LYMPHOMA; HYPOTHYROIDISM; INDEPENDENT PREDICTORS; INVOLVED FIELD; MULTI VARIATE ANALYSIS; MULTIVARIATE LOGISTIC REGRESSIONS; NORMAL TISSUE COMPLICATION PROBABILITIES; ODDS RATIOS; RADIATION-INDUCED; SIDE EFFECT; THYROGLOBULIN; THYROID GLANDS; THYROID VOLUME; TREATMENT PLANNING; UNIVARIATE; UNIVARIATE ANALYSIS;

CHEMORADIOTHERAPY; CHEMOTHERAPY; DOSIMETERS; DOSIMETRY; PATIENT MONITORING; RADIOTHERAPY; REGRESSION ANALYSIS; THREE DIMENSIONAL; TISSUE;

ONCOLOGY;

BLEOMYCIN; DACARBAZINE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; LIOTHYRONINE; PREDNISONE; THYROGLOBULIN ANTIBODY; THYROTROPIN; THYROXINE; VINBLASTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CHEMORADIOTHERAPY; DOSIMETRY; FEMALE; FOLLOW UP; HODGKIN DISEASE; HUMAN; HYPOTHYROIDISM; LIOTHYRONINE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION INDUCED HYPOTHYROIDISM; RETROSPECTIVE STUDY; THYROID GLAND; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMORADIOTHERAPY; FEMALE; HODGKIN DISEASE; HUMANS; HYPOTHYROIDISM; MALE; MIDDLE AGED; ORGAN SIZE; RADIOTHERAPY DOSAGE; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; THYROGLOBULIN; THYROID GLAND; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE; YOUNG ADULT;

EID: 84858683517     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.09.054     Document Type: Article

References (36)

1. Einhorn J,Wilkholm G. Hypothyroidism after external irradiation to the thyroid region. Radiology 1967;88:326-328.
2. Colevas AD, Read R, Thornhill J, et al. Hypothyroidism incidence after multimodality treatment for stage III and IV squamous cell carcinomas of the head and neck. Int J Radiat Oncol Biol Phys 2001;51:599-604.
3. Kumpulainen EJ, Hirvikoski PP, Virtaniemi JA, et al. Hypothyroidism after radiotherapy for laryngeal cancer. Radiother Oncol 2000;57:97-101.
4. Jereczek-Fossa BA, Alterio D, Jassem J, et al. Radiotherapy-induced thyroid disorders. Cancer Treat Rev 2004;30:369-384. (Pubitemid 38744493)
5. Alterio D, Jereczek-Fossa BA, Franchi B, et al. Thyroid disorders in patients treated with radiotherapy for head-and-neck cancer: A retrospective analysis of seventy-three patients. Int J Radiat Oncol Biol Phys 2007;67:144-150. (Pubitemid 44959500)
6. Weissler MC, Berry BW. Thyroid-stimulating hormone levels after radiotherapy and combined therapy for head and neck cancer. Head Neck 1991;13:420-423.
7. Hancock SL, Cox RS, McDougall IR.Thyroiddiseases after treatment of Hodgkin's disease. N Engl J Med 1991;325:599-605.
8. Nelson DF, Reddy KV, O'Mara RE, et al. Thyroid abnormalities following neck irradiation for Hodgkin's disease. Cancer 1978;42:2553-2562. (Pubitemid 9095023)
9. Constine LS, Donaldson SS, McDougall IR, et al. Thyroid dysfunction after radiotherapy in children with Hodgkin's disease. Cancer 1984;53:878-883. (Pubitemid 14183747)
10. Glatstein E, McHardy-Young S, Brast N, et al. Alterations in serum thyrotropin (TSH) and thyroid function following radiotherapy in patients with malignant lymphoma. J Clin Endocrinol Metab 1971;32:833-841.
11. Bhatia S, Ramsay NK, Bantle JP, et al. Thyroid Abnormalities after Therapy for Hodgkin's Disease in Childhood. Oncologist 1996;1:62-67. (Pubitemid 126669373)
12. Bethge W, Guggenberger D, Bamberg M, et al. Thyroid toxicity of treatment for Hodgkin's disease. Ann Hematol 2000;79: 114-118. (Pubitemid 30195607)
13. Ladenson PW, Singer PA, Ain KB, et al. American Thyroid Association guidelines for detection of thyroid dysfunction. Arch Intern Med 2000;160:1573-1575. (Pubitemid 30367894)
14. Kuten A, Lubochitski R, Fishman G, et al. Postradiotherapy hypothyroidism: Radiation dose response and chemotherapeutic radiosensitization at less than 40 Gy. J Surg Oncol 1996;61: 281-283. (Pubitemid 26117121)
15. von der Weid NX. Adult life after surviving lymphoma in childhood. Support Care Cancer 2008;16:339-345.
16. Sklar C, Whitton J, Mertens A, et al. Abnormalities of the thyroid in survivors of Hodgkin's disease: Data from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 2000; 85:3227-3232.
17. Chow LM, Nathan PC, Hodgson DC, et al. Survival and late effects in children with Hodgkin's lymphoma treated with MOPP/ABV and low-dose, extended-field irradiation. J Clin Oncol 2006;24:5735-5741.
18. Hancock SL, McDougall IR, Constine LS. Thyroid abnormalities after therapeutic external radiation. Int J Radiat Oncol Biol Phys 1995;31:1165-1170.
19. Milano MT, Constine LS, Okunieff P. Normal tissue tolerance dose metrics for radiation therapy of major organs. Semin Radiat Oncol 2007;17:131-140. (Pubitemid 46467383)
20. Marks LB, Ten Haken RK, Martel MK. Guest editor's introduction to QUANTEC: A users guide. Int J Radiat Oncol Biol Phys 2010;76:S1-S2.
21. Akgun Z, Atasoy B, Ozen Z, Gulluoglu B, Abacioglu MU. Dosimetric analysis for thyroid disorders after radiotherapy to the neck. J Clin Oncol 2009;27(15S):abstr e17025.
22. Yoden E, Maruta T, Soejima T, et al. Hypothyroidism after radiotherapy to the neck [Abstract]. Int J Radiat Oncol Biol Phys 2001;51:337-338.
23. Chera BS, Rodriguez C, Morris CG, et al. Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: Conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy. Int J Radiat Oncol Biol Phys 2009;75: 1173-1180.
24. Girinsky T, van der Maazen R, Specht L, et al. Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: Concepts and guidelines. Radiother Oncol 2006;79: 270-277. (Pubitemid 44109907)
25. Goodman KA, Toner S, Hunt M, et al. Intensity-modulated radiotherapy for lymphoma involving the mediastinum. Int J Radiat Oncol Biol Phys 2005;62:198-206. (Pubitemid 40591943)
26. MacDonald S, Bernard S, Balogh A, et al. Electronic compensation using multileaf collimation for involved field radiation to the neck and mediastinum in non-Hodgkin's lymphoma and Hodgkin's lymphoma. Med Dosim 2005;30:59-64. (Pubitemid 40732457)
27. Prabhakar R, Haresh KP, Sridhar PS, et al. Execution of mantle field with multileaf collimator: A simple approach. J Cancer Res Ther 2008;4:18-20. (Pubitemid 351555997)
28. Vlachaki MT, Kumar S. Helical tomotherapy in the radiotherapy treatment of Hodgkin's disease-a feasibility study. J Appl Clin Med Phys 2010;11:3042.
29. Cella L, Liuzzi R, Magliulo M, et al. Radiotherapy of large target volumes in Hodgkin's lymphoma: Normal tissue sparing capability of forward IMRT versus conventional techniques. Radiat Oncol 2010;5:33.
30. Lyman JT,Wolbarst AB. Optimization of radiation therapy, III: A method of assessing complication probabilities from dosevolume histograms. Int J Radiat Oncol Biol Phys 1987;13: 103-109. (Pubitemid 17023453)
31. Kutcher GJ, Burman C. Calculation of complication probability factors for non-uniform normal tissue irradiation: The effective volume method. Int J Radiat Oncol Biol Phys 1989;16: 1623-1630. (Pubitemid 19154353)
32. Burman C, Kutcher GJ, Emami B, et al. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys 1991;21:123-135.
33. Vanderpump MP, Tunbridge WM, French JM, et al. The incidence of thyroid disorders in the community: A twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 1995;43:55-68.
34. Gharib H, Tuttle RM, Baskin HJ, et al. Subclinical thyroid dysfunction: A joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society. J Clin Endocrinol Metab 2005;90:581-585; discussion 586-587.
35. SuSY,Grodski S, Serpell JW. Hypothyroidism following hemithyroidectomy: A retrospective review. Ann Surg 2009;250:991-994.
36. Engert A, Plutschow A, Eich HT, et al. Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma. N Engl J Med 2010;363:640-652.